自己免疫疾患検査の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Autoimmune Disease Diagnostics Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Autoimmune diseases

PART 05: Market landscape
• Market overview
• Five forces analysis

PART 06: Market segmentation by disease type
• Systemic autoimmune disease diagnostics
• Global systemic autoimmune disease market overview
• Localized autoimmune disease diagnostics
• Global localized autoimmune disease diagnostics market overview

PART 07: Market segmentation by product type
• Analyzers
• Global autoimmune diseases analyzers market overview
• Assay kits
• Global autoimmune disease assay kits market overview

PART 08: Market segmentation by test type
• ANA tests
• CRP
• Urinalysis test
• ESR
• CMP test
• Other

PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic and research laboratories

PART 10: Geographical segmentation
• Autoimmune disease diagnostics market in Americas
• Autoimmune disease diagnostics market in EMEA
• Autoimmune disease diagnostics market in APAC

PART 11: Market drivers
• Discovery of novel biomarkers leading to improved autoimmune diagnosis
• Advancements in laboratory automation platforms
• Increasing M&A
• Product approvals and launches

PART 12: Impact of drivers

PART 13: Market challenges
• Limitation of autoimmune disease diagnostics
• Significant concerns over standardization and quality of immunoassay kits
• Lack of understanding on the basic etiology of several autoimmune diseases
• Shortage of skilled technicians for performing diagnostic assays

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Focus on companion diagnostic tests
• Shift from monoplex to multiplex testing
• Collaboration between pharma and diagnostic companies
• Growing consumer shift toward direct-to-consumer testing

PART 16: Vendor landscape
• Competitive scenario
• Key news
• Vendors market share 2015

PART 17: Key vendor analysis
• Abbott Laboratories
• Beckman Coulter
• Bio-Rad Laboratories
• EUROIMMUN
• Inova Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

Exhibit 01: Product offerings
Exhibit 02: Etiology of autoimmune diseases
Exhibit 03: Signs and symptoms of autoimmune diseases
Exhibit 04: Average annual treatment cost of RA in US and Europe 2014 ($ billions)
Exhibit 05: Average annual treatment costs of multiple sclerosis across countries 2014 ($ billions)
Exhibit 06: Snapshot of global autoimmune disease diagnostics market 2016-2021
Exhibit 07: Global autoimmune disease diagnostics market snapshot
Exhibit 08: Key trends in global autoimmune disease diagnostics market
Exhibit 09: Global autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 10: Opportunity analysis in developed and emerging markets
Exhibit 11: Opportunity analysis of global autoimmune diagnostics market
Exhibit 12: Five forces analysis
Exhibit 13: Global autoimmune disease diagnostics market segmentation by disease type
Exhibit 14: Global systemic autoimmune disease diagnostics market 2016
Exhibit 15: Global localized autoimmune disease diagnostics market 2016
Exhibit 16: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 17: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 18: Antibodies for diagnosis of different systemic autoimmune diseases
Exhibit 19: Global systemic autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 20: Global RA diagnostics market 2016-2021 ($ millions)
Exhibit 21: Prevalence and incidence of SLE
Exhibit 22: Global SLE diagnostics market overview 2016-2021 ($ millions)
Exhibit 23: Global systemic autoimmune disease diagnostics market measurement parameters
Exhibit 24: Opportunity analysis of systemic autoimmune disease market
Exhibit 25: Antibodies used for diagnosis of different localized autoimmune diseases
Exhibit 26: Global localized autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 27: Opportunity analysis of localized autoimmune disease diagnostics market
Exhibit 28: Global type 1 diabetes diagnostics market 2016-2021 ($ millions)
Exhibit 29: Global autoimmune thyroiditis diagnostics market 2016-2021 ($ millions)
Exhibit 30: Global localized autoimmune disease diagnostics market measurement parameters
Exhibit 31: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021 ($ millions)
Exhibit 32: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021
Exhibit 33: Analysis of autoimmune disease diagnostics market segmentation by disease type
Exhibit 34: Global autoimmune disease diagnostics market segmentation by product type
Exhibit 35: Global autoimmune disease diagnostics market segmentation by product type 2016-2021
Exhibit 36: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 37: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 38: Some of the analyzers developed by vendors
Exhibit 39: Global autoimmune diseases analyzers market 2016-2021 ($ millions)
Exhibit 40: Opportunity analysis of autoimmune disease analyzers market
Exhibit 41: Some of the assays kits available in the market
Exhibit 42: Some of the key news related to assay kits
Exhibit 43: Global autoimmune diseases assay kits market 2016-2021 ($ millions)
Exhibit 44: Opportunity analysis for autoimmune disease assay kits
Exhibit 45: Analysis of autoimmune disease diagnostics market by product type
Exhibit 46: Global autoimmune disease diagnostics market by product type 2016-2021 ($ millions)
Exhibit 47: Global autoimmune disease diagnostics market by product type 2016-2021
Exhibit 48: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 49: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 50: Some of the examples of ANA tests
Exhibit 51: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 52: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 53: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 54: Global autoimmune disease diagnostics market segmentation by geography 2016-2021 ($ millions)
Exhibit 55: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 56: Americas: Market overview of autoimmune disease diagnostics
Exhibit 57: Comparison of US healthcare system: Before and after reforms
Exhibit 58: Autoimmune disease diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 59: Autoimmune disease diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 60: EMEA: Market overview of autoimmune disease diagnostics
Exhibit 61: APAC: Market overview of autoimmune disease diagnostics
Exhibit 62: Autoimmune disease diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 63: Key initiatives of vendors fueling the launch of novel biomarkers
Exhibit 64: Key highlights of laboratory automation
Exhibit 65: Some of the consolidations witnessed during 2015-2016
Exhibit 66: Impact of drivers
Exhibit 67: Force field analysis of global autoimmune disease diagnostics market
Exhibit 68: Impact of drivers and challenges
Exhibit 69: Impact of trends on global autoimmune disease diagnostics market
Exhibit 70: Vendors’ product development strategy for end-users
Exhibit 71: Competitive structure analysis of global autoimmune diagnostics market 2017-2021
Exhibit 72: Strategic success factors for companies in global autoimmune disease diagnostics market
Exhibit 73: Market penetration analysis of key vendors in autoimmune disease diagnostics 2015
Exhibit 74: Vendors’ market share breakdown 2015
Exhibit 75: Abbott Laboratories: Profile
Exhibit 76: Abbott Laboratories: Strength assessment
Exhibit 77: Abbott Laboratories: Strategy assessment
Exhibit 78: Abbott Laboratories: Opportunity assessment
Exhibit 79: Beckman Coulter: Key highlights
Exhibit 80: Beckman Coulter: Strength assessment
Exhibit 81: Beckman Coulter: Strategy assessment
Exhibit 82: Beckman Coulter: Opportunity assessment
Exhibit 83: Bio-Rad Laboratories: Key highlights
Exhibit 84: Bio-Rad Laboratories: Strength assessment
Exhibit 85: Bio-Rad Laboratories: Strategy assessment
Exhibit 86: Bio-Rad Laboratories: Opportunity assessment
Exhibit 87: EUROIMMUN: Profile
Exhibit 88: EUROIMMUN: Strength assessment
Exhibit 89: EUROIMMUN: Strategy assessment
Exhibit 90: EUROIMMUN: Opportunity assessment
Exhibit 91: Inova Diagnostics: Key highlights
Exhibit 92: Inova Diagnostics: Strength assessment
Exhibit 93: Inova Diagnostics: Strategy assessment
Exhibit 94: Inova Diagnostics: Opportunity assessment
Exhibit 95: Roche Diagnostics: Key highlights
Exhibit 96: Roche Diagnostics: Strength assessment
Exhibit 97: Roche Diagnostics: Strategy assessment
Exhibit 98: Roche Diagnostics: Opportunity assessment
Exhibit 99: Siemens Healthcare: Key highlights
Exhibit 100: Siemens Healthcare: Strength assessment
Exhibit 101: Siemens Healthcare: Strategy assessment
Exhibit 102: Siemens Healthcare: Opportunity assessment


【レポート販売概要】

■ タイトル:自己免疫疾患検査の世界市場2017-2021
■ 英文:Global Autoimmune Disease Diagnostics Market 2017-2021
■ 発行日:2016年9月30日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10562
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。